| Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer MJ Watt, AK Clark, LA Selth, VR Haynes, N Lister, R Rebello, LH Porter, ... Science translational medicine 11 (478), eaau5758, 2019 | 295 | 2019 |
| Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ... Nature communications 8 (1), 13671, 2017 | 247 | 2017 |
| Estrogen receptor–β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediated SJ McPherson, S Hussain, P Balanathan, SL Hedwards, B Niranjan, ... Proceedings of the National Academy of Sciences 107 (7), 3123-3128, 2010 | 239 | 2010 |
| Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones RA Jarred, M Keikha, C Dowling, SJ McPherson, AM Clare, AJ Husband, ... Cancer Epidemiology Biomarkers & Prevention 11 (12), 1689-1696, 2002 | 189 | 2002 |
| Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor … GP Risbridger, RA Taylor, D Clouston, A Sliwinski, H Thorne, S Hunter, ... European Urology 67 (3), 496-503, 2015 | 158 | 2015 |
| Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues A Raajendiran, G Ooi, J Bayliss, PE O’Brien, RB Schittenhelm, AK Clark, ... Cell reports 27 (5), 1528-1540. e7, 2019 | 137 | 2019 |
| Direct response of the murine prostate gland and seminal vesicles to estradiol JJ Bianco, DJ Handelsman, JS Pedersen, GP Risbridger Endocrinology 143 (12), 4922-4933, 2002 | 126 | 2002 |
| Evidence for Efficacy of New Hsp90 Inhibitors Revealed by Ex Vivo Culture of Human Prostate Tumors MM Centenera, JL Gillis, AR Hanson, S Jindal, RA Taylor, GP Risbridger, ... Clinical Cancer Research 18 (13), 3562-3570, 2012 | 125 | 2012 |
| A preclinical xenograft model of prostate cancer using human tumors MG Lawrence, RA Taylor, R Toivanen, J Pedersen, S Norden, DW Pook, ... Nature protocols 8 (5), 836-848, 2013 | 122 | 2013 |
| Formation of human prostate tissue from embryonic stem cells RA Taylor, PA Cowin, GR Cunha, M Pera, AO Trounson, J Pedersen, ... Nature methods 3 (3), 179-181, 2006 | 118 | 2006 |
| Evidence that estrogens directly alter androgen-regulated prostate development RA Jarred, B Cancilla, GS Prins, KA Thayer, GR Cunha, GP Risbridger Endocrinology 141 (9), 3471-3477, 2000 | 117 | 2000 |
| Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status RA Taylor, R Toivanen, M Frydenberg, J Pedersen, L Harewood, ... Stem cells 30 (6), 1087-1096, 2012 | 116 | 2012 |
| Stem cells in prostate cancer: treating the root of the problem RA Taylor, R Toivanen, GP Risbridger Endocrine-related cancer 17 (4), R273-R285, 2010 | 109 | 2010 |
| Patient-derived models of abiraterone-and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy MG Lawrence, D Obinata, S Sandhu, LA Selth, SQ Wong, LH Porter, ... European urology 74 (5), 562-572, 2018 | 105 | 2018 |
| Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories LH Porter, MG Lawrence, D Ilic, D Clouston, DM Bolton, M Frydenberg, ... European urology 72 (4), 492-495, 2017 | 105 | 2017 |
| Prostatic tumor stroma: a key player in cancer progression RA Taylor, GP Risbridger Current cancer drug targets 8 (6), 490-497, 2008 | 101 | 2008 |
| Enduring epigenetic landmarks define the cancer microenvironment R Pidsley, MG Lawrence, E Zotenko, B Niranjan, A Statham, J Song, ... Genome research 28 (5), 625-638, 2018 | 96 | 2018 |
| Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient‐derived xenograft (PDX) models NM Navone, WM van Weerden, RL Vessella, ED Williams, Y Wang, ... The Prostate 78 (16), 1262-1282, 2018 | 93 | 2018 |
| Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome DA Leach, EF Need, R Toivanen, AP Trotta, HM Palenthorpe, DJ Tamblyn, ... Oncotarget 6 (18), 16135, 2015 | 93 | 2015 |
| Proteomic profiling of human prostate Cancer-associated fibroblasts (CAF) reveals LOXL2-dependent regulation of the tumor microenvironment*[S] EV Nguyen, BA Pereira, MG Lawrence, X Ma, RJ Rebello, H Chan, ... Molecular & Cellular Proteomics 18 (7), 1410-1427, 2019 | 91 | 2019 |
Gail RisbridgerMonash UniversityVerified email at monash.edu
